Bergers, Gabriele
Fendt, Sarah-Maria https://orcid.org/0000-0001-6018-9296
Article History
Accepted: 11 November 2020
First Online: 18 January 2021
Competing interests
: S.-M.F. has received funding from Bayer, Merck and BlackBelt Therapeutics and has consulted for Fund+. G.B. declares no competing interests.